RU2017144237A - Способ получения супрамолекулярных платиновых соединений - Google Patents

Способ получения супрамолекулярных платиновых соединений Download PDF

Info

Publication number
RU2017144237A
RU2017144237A RU2017144237A RU2017144237A RU2017144237A RU 2017144237 A RU2017144237 A RU 2017144237A RU 2017144237 A RU2017144237 A RU 2017144237A RU 2017144237 A RU2017144237 A RU 2017144237A RU 2017144237 A RU2017144237 A RU 2017144237A
Authority
RU
Russia
Prior art keywords
water
salt
platinum compound
lipid
conjugated
Prior art date
Application number
RU2017144237A
Other languages
English (en)
Russian (ru)
Other versions
RU2017144237A3 (https=
Inventor
Нимиш ГУПТА
Ариндам САРКАР
Хеералал БАССИ
Прадип ДУТТА
Original Assignee
Акамара Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Акамара Терапьютикс, Инк. filed Critical Акамара Терапьютикс, Инк.
Publication of RU2017144237A publication Critical patent/RU2017144237A/ru
Publication of RU2017144237A3 publication Critical patent/RU2017144237A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0013—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RU2017144237A 2015-05-19 2016-05-18 Способ получения супрамолекулярных платиновых соединений RU2017144237A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1418/DEL/2015 2015-05-19
IN1418DE2015 2015-05-19
PCT/IB2016/052901 WO2016185402A1 (en) 2015-05-19 2016-05-18 Process for preparing supramolecular platinum-based compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2020105878A Division RU2795256C2 (ru) 2015-05-19 2016-05-18 Способ получения супрамолекулярных платиновых соединений

Publications (2)

Publication Number Publication Date
RU2017144237A true RU2017144237A (ru) 2019-06-20
RU2017144237A3 RU2017144237A3 (https=) 2019-07-24

Family

ID=56203430

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017144237A RU2017144237A (ru) 2015-05-19 2016-05-18 Способ получения супрамолекулярных платиновых соединений

Country Status (13)

Country Link
US (1) US11358978B2 (https=)
EP (1) EP3297681B1 (https=)
JP (1) JP2018520206A (https=)
KR (1) KR20180008638A (https=)
CN (1) CN107847457B (https=)
AU (1) AU2016263076B2 (https=)
BR (1) BR112017024759A2 (https=)
CA (1) CA2986358A1 (https=)
ES (1) ES2918385T3 (https=)
MX (1) MX378821B (https=)
RU (1) RU2017144237A (https=)
WO (1) WO2016185402A1 (https=)
ZA (1) ZA201707944B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017266564A1 (en) 2016-05-18 2018-12-06 Akamara Therapeutics, Inc. Crystalline platinum-based compounds
US20220168261A1 (en) * 2019-02-14 2022-06-02 Akamara Therapeutics, Inc. Compounds and methods for managing cancer through immune system

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4737323A (en) 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
US4946954A (en) 1989-01-17 1990-08-07 Georgetown University Platinum pharmaceutical agents
FR2645866B1 (fr) 1989-04-17 1991-07-05 Centre Nat Rech Scient Nouvelles lipopolyamines, leur preparation et leur emploi
JPH07247250A (ja) * 1994-03-09 1995-09-26 Doujin Kagaku Kenkyusho:Kk アミノオキシアルキルイミノジ酢酸及びその誘導体
US5885613A (en) 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
IL115849A0 (en) 1994-11-03 1996-01-31 Merz & Co Gmbh & Co Tangential filtration preparation of liposomal drugs and liposome product thereof
CA2220950A1 (en) 1995-05-26 1996-11-28 Somatix Therapy Corporation Delivery vehicles comprising stable lipid/nucleic acid complexes
DE69913368T2 (de) * 1998-10-23 2004-10-28 Institut National de la Santé et de la Recherche Médicale I.N.S.E.R.M. Chelatiermittel für radioimmunotherapie
US7897638B2 (en) * 2005-04-12 2011-03-01 Philadelphia Health & Education Corporation Synthesis of nitrodibenzylfuran chromophore for photodeprotection of organic molecules
US9393227B2 (en) 2009-02-04 2016-07-19 The Brigham And Women's Hospital, Inc. Nanoscale platinum compounds and methods of use thereof
AU2014278011B2 (en) * 2013-06-14 2020-03-19 Alyssum Therapeutics, Inc. Lipid-based platinum compounds and nanoparticles

Also Published As

Publication number Publication date
WO2016185402A8 (en) 2017-02-16
KR20180008638A (ko) 2018-01-24
BR112017024759A2 (pt) 2018-11-13
US11358978B2 (en) 2022-06-14
RU2017144237A3 (https=) 2019-07-24
MX2017014841A (es) 2018-03-22
AU2016263076B2 (en) 2021-10-07
EP3297681B1 (en) 2022-03-16
AU2016263076A1 (en) 2017-12-07
RU2020105878A3 (https=) 2020-08-18
RU2020105878A (ru) 2020-03-24
JP2018520206A (ja) 2018-07-26
ZA201707944B (en) 2021-05-26
EP3297681A1 (en) 2018-03-28
CN107847457B (zh) 2022-07-05
MX378821B (es) 2025-03-10
CA2986358A1 (en) 2016-11-24
ES2918385T3 (es) 2022-07-15
CN107847457A (zh) 2018-03-27
WO2016185402A1 (en) 2016-11-24
US20200016113A1 (en) 2020-01-16

Similar Documents

Publication Publication Date Title
RU2019101651A (ru) Соединения на основе платины и липидов и наночастицы
KR850000584B1 (ko) 수성 콜로이드 조성물의 제조방법
JP2011503188A (ja) ステロール修飾両親媒性脂質
WO2009115023A1 (zh) 花色苷磷脂复合物及其制备方法
WO2017221270A1 (en) Conjugated anti-proliferative drug nano-particles and process for preparation thereof
RU2017144237A (ru) Способ получения супрамолекулярных платиновых соединений
He et al. Self‐assembly of Pyrene‐modified Rhomboidal Metallodendrimers via Directional Metal‐ligand Bonding Approach
Yu et al. Simple weak-acid derivatives of paclitaxel for remote loading into liposomes and improved therapeutic effects
US6111123A (en) Salicylaldimine-crown ether ditopic receptor molecules
KR20190022796A (ko) 인지질 조성물들
WO2015110040A1 (zh) 苯丁酸氮芥衍生物、制备方法及应用
JP2018520206A5 (https=)
Cao et al. Enhanced oral bioavailability of oleanolic acid in rats with phospholipid complex
EP3251658B1 (en) Liposome composition using sugar alcohol with modified surface area and/or porosity as carrier and method for preparing the same
CN106177976B (zh) 一种阿司匹林磷脂复合物及其制备方法
JP4972352B2 (ja) ホウ素含有化合物およびこれを用いたリポソーム
RU2795256C2 (ru) Способ получения супрамолекулярных платиновых соединений
CN120398711A (zh) 可电离脂质、其制备方法、和用于制备脂质纳米粒子的组合物
CN121287626A (zh) 一种黄芪甲苷脂质体制备方法及应用
Kaourma et al. Development of simple thiol‐reactive liposome formulations, one‐step analysis and physicochemical characterization
Koyanagi Design and Synthesis of Archaea-inspired Tetraether Lipids
OA20568A (en) Micromolecule PI4Klllα inhibitor composition, preparation method therefor and use thereof.
Sandborn The Preparation of Ion Pairs for Potential Enhancement of Drug Delivery to the Central Nervous System
CN119280161A (zh) 吉非替尼脂质体复合物及其制备方法
PL236558B1 (pl) 1’-(3,7,11,15-Tetrametylo-3-winyloheksadekanoilo)-2’-palmitoilosn- glicero-3’-fosfocholina oraz sposób jej otrzymywania

Legal Events

Date Code Title Description
FA94 Acknowledgement of application withdrawn (non-payment of fees)

Effective date: 20210222